TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Jonel Pasula Reumatolog AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 32 | 44 | 15 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 23 | -16 | -22 |
EBITDA | 9 | -17 | -22 |
Total assets | 749 | 921 | 1,090 |
Current assets | 750 | 921 | 1,090 |
Current liabilities | 475 | 498 | 650 |
Equity capital | 261 | 404 | 417 |
- share capital | 100 | 100 | 100 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 34.8% | 43.9% | 38.3% |
Turnover per employee | 32 | 44 | 15 |
Profit as a percentage of turnover | 71.9% | -36.4% | -146.7% |
Return on assets (ROA) | 3.1% | -1.7% | -2.0% |
Current ratio | 157.9% | 184.9% | 167.7% |
Return on equity (ROE) | 8.8% | -4.0% | -5.3% |
Change turnover | -12 | 29 | -23 |
Change turnover % | -27% | 193% | -61% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.